14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NVAX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Wednesday for Novavax stock after losing 0.95%
(Updated on Apr 24, 2024)

Hold candidate since Apr 23, 2024 Loss -0.95% PDF

The Novavax stock price fell by -0.95% on the last day (Wednesday, 24th Apr 2024) from $4.19 to $4.15. During the last trading day the stock fluctuated 3.90% from a day low at $4.10 to a day high of $4.26. The price has fallen in 5 of the last 10 days and is down by -2.58% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 2 million shares were bought and sold for approximately $10.09 million.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.90 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 2.82% during the next 3 months and, with a 90% probability hold a price between $4.01 and $6.30 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NVAX Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 6.68%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Novavax stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $4.64. On a fall, the stock will find some support from the short-term average at $4.02. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Novavax stock

Novavax finds support from accumulated volume at $4.10 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.160 between high and low, or 3.90%. For the last week, the stock has had daily average volatility of 4.97%.

Our recommended stop-loss: $3.97 (-4.30%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 5 days ago.)

Trading Expectations (NVAX) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Novavax Inc to open at $4.17, and during the day (based on 14 day Average True Range), to move between $3.90 and $4.40, which gives a possible trading interval of +/-$0.248 (+/-5.98%) up or down from last closing price. If Novavax Inc takes out the full calculated possible swing range there will be an estimated 11.97% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.10 (1.20%) than the resistance at $4.41 (6.27%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Novavax Inc stock A Buy?

Novavax holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.810 Hold/Accumulate Unchanged

Predicted Opening Price for Novavax Inc of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$4.17 ( 0.482%) $4.15

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NVAX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.33 4.34 %
R2 4.27 2.86 %
R1 4.23 1.95 %
Current price: 4.15
Support S1 4.11 -0.99 %
S2 4.07 -1.90 %
S3 4.01 -3.37 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.94 19.04 %
R2 4.88 17.59 %
R1 4.41 6.27 %
Current price 4.15
Support S1 4.10 -1.20%
S2 4.03 -2.89%
S3 3.93 -5.30%

FAQ

What is the symbol for Novavax Stock and on which exchange is it traded?
The symbol for Novavax is NVAX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Novavax Stock?
Novavax holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Novavax Stock?
Novavax Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Novavax Stock.

What's the current price of Novavax Stock?
As of the end of day on the Apr 24, 2024, the price of an Novavax (NVAX) share was $4.15.

What is the 52-week high and low for Novavax Stock?
The 52-week high for Novavax Stock is $11.36 and the 52-week low is $3.53.

What is the market capitalization of Novavax Stock?
As of the Apr 24, 2024, the market capitalization of Novavax is 586.403M.

When is the next earnings date for Novavax?
The upcoming earnings date for Novavax is May 14, 2024.
Click to get the best stock tips daily for free!

About Novavax Inc

Novavax Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria... NVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT